Does BOTULINUM TOXIN TYPE A Cause Psoriatic arthropathy? 557 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 557 reports of Psoriatic arthropathy have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 14.9% of all adverse event reports for BOTULINUM TOXIN TYPE A.
557
Reports of Psoriatic arthropathy with BOTULINUM TOXIN TYPE A
14.9%
of all BOTULINUM TOXIN TYPE A reports
557
Deaths
476
Hospitalizations
How Dangerous Is Psoriatic arthropathy From BOTULINUM TOXIN TYPE A?
Of the 557 reports, 557 (100.0%) resulted in death, 476 (85.5%) required hospitalization, and 486 (87.3%) were considered life-threatening.
Is Psoriatic arthropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 557 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Psoriatic arthropathy?
SECUKINUMAB (8,900)
ADALIMUMAB (8,148)
METHOTREXATE (7,167)
APREMILAST (7,035)
ETANERCEPT (6,518)
CERTOLIZUMAB PEGOL (5,798)
LEFLUNOMIDE (4,703)
INFLIXIMAB (4,238)
GOLIMUMAB (4,101)
SULFASALAZINE (3,961)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Psoriatic arthropathy Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE